Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression.

Journal: Cell

Published: 2020-07-09

DOI: 10.1016/j.cell.2020.06.012

Affiliations: 23

Authors: 47

Go to article
Institutions Share
Institute of Chemistry, Academia Sinica, Taiwan 0.22
Department of Clinical Laboratory Sciences and Medical Biotechnology, NTU, Taiwan 0.13
Institute of Statistical Science, Academia Sinica, Taiwan 0.09
Agricultural Biotechnology Research Center (ABRC), Academia Sinica, Taiwan 0.06
Institute of Information Science, Academia Sinica, Taiwan 0.06
Department of Pathology, NTUH, Taiwan 0.06
Department of Surgery, NTUH, Taiwan 0.06
NIH NCI Office of Cancer Clinical Proteomics Research (OCCPR), United States of America (USA) 0.04
ICR Functional Proteomics Group, United Kingdom (UK) 0.04
Computational Biology Unit (CBU), UIB, Norway 0.04
National Center for High-performance Computing (NCHC), NARLabs, Taiwan 0.02
Graduate Institute of Toxicology, NTU, Taiwan 0.02
Department of Laboratory Medicine, NTUH, Taiwan 0.02
School of Pharmacy, TMU, Taiwan 0.02
Institute of Molecular Medicine, NTU, Taiwan 0.02
Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan 0.01
Taiwan International Graduate Program in BIOinformatics (TIGP-BIO), Taiwan 0.01
Biotechnology Center (BTC), NCHU, Taiwan 0.01
Department of Internal Medicine, NTUH, Taiwan 0.01
Department of Chemistry, NTU, Taiwan 0.01
Faculty of Medicine, NYMU, Taiwan 0.01
Institute of Biomedical Sciences (IBMS), Academia Sinica, Taiwan 0.01